Alveus
0 followers
About Alveus
Alveus Therapeutics is a biotech company focused on developing next-generation metabolic therapies for obesity and related metabolic diseases. It builds a differentiated portfolio aimed at sustainable weight loss with superior tolerability, seeking to improve patient outcomes and address weight maintenance challenges. The company emphasizes a science-driven approach that leverages human genetic data, deep biological expertise, and rigorous program selection to pursue first- or best-in-class molecules, with its lead asset ALV-100 in Phase 2 and a preclinical amylin pipeline. Operations appear based in the United States and Denmark with a global research focus in metabolic disease.